Bicara – Talk Bio

Actionable Insights Powered by AI

Bicara and Zenas File for IPOs to Advance Late-Phase Cancer and Autoimmune Treatments

Bicara Therapeutics, Zenas BioPharma, IPO, cancer treatment, autoimmune disease, biotech, pharmaceuticals